19 April 2016

Collagen Solutions Plc Supplies Collagen Materials to Merck

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it has completed a supply agreement with Merck Ag. Under the agreement, researchers worldwide will have access to Collagen Solutions' medical-grade collagen products through Merck's broad distribution network.

Dr. Stewart White, Chief Executive Officer of Collagen Solutions plc said, "Our agreement with Merck makes our high quality range of medical grade collagen products available to the research market. Researchers need to know that the material they use in the laboratory is consistent and can be scaled up without any loss of quality or change in characteristics. This means that they can start with material which is suitable for medical applications from the earliest stage in their research and do not have to switch suppliers when they reach commercialisation."

Collagen Solutions provides the highest quality, medical grade biomaterials to support medical devices and other products for regenerative medicine across a wide range of applications and clinical indications. The Collagen Solutions Group also provides collagen for use as a research reagent and for use in diagnostics.



Collagen Solutions Plc  
David Evans, Chairman Tel: 07740 084 452
Stewart White, CEO Tel: 0141 648 9100
Panmure Gordon & Co  
Robert Naylor (Corporate Finance) Tel: 020 7886 2714
Maisie Atkinson (Corporate Broking) Tel: 020 7886 2905
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Mike Wort Mob: 07900 608 002
Anna Dunphy Mob: 07876 741 001